Literature DB >> 8956326

Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells.

K M Covitz1, G L Amidon, W Sadée.   

Abstract

PURPOSE: A cDNA encoding the H(+)-coupled peptide transporter, hPEPT1, has previously been cloned from human ileum (8). The objective of this study was to establish a stably transfected cell line expressing hPEPT1 in mammalian cell culture.
METHODS: The hPEPT1 cDNA was subcloned into an expression vector carrying the CMV promoter and a neomycin resistance gene. This vector, pCDNA3-PEPT1, was transiently transfected into several cell lines to identify those capable of expressing PEPT1 transport function. CHO cells were selected and stably transfected with PEPT1 (CHO-PEPT1). Dipeptide transport activity was measured with 3H-Gly-Sar, in the presence and absence of inhibitors.
RESULTS: The clonal cell line, CHO-PEPT1, displayed high transport activity. Dipeptide transport was sensitive to pH and specific for dipeptides and other small peptides. Peptidomimetic antibiotics, such as cephalexin, were competitors for peptide transport.
CONCLUSIONS: The stably transfected cell line, CHO-PEPT1 exhibits enhanced transport over that of cell lines with native expression of PEPT1, and therefore, represents a useful tool for rapid screening of drugs that utilize the peptide transporter in the human intestine for absorption.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956326     DOI: 10.1023/a:1016476220296

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

Review 1.  Is intestinal peptide transport energized by a proton gradient?

Authors:  F H Leibach
Journal:  Am J Physiol       Date:  1985-08

2.  Enhanced efflux of [3H]vinblastine from Chinese hamster ovary cells transfected with a full-length complementary DNA clone for the mdr1 gene.

Authors:  J R Hammond; R M Johnstone; P Gros
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

3.  Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.

Authors:  A H Dantzig; L Bergin
Journal:  Biochim Biophys Acta       Date:  1990-09-07

4.  Association of intestinal peptide transport with a protein related to the cadherin superfamily.

Authors:  A H Dantzig; J A Hoskins; L B Tabas; S Bright; R L Shepard; I L Jenkins; D C Duckworth; J R Sportsman; D Mackensen; P R Rosteck
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

5.  Expression cloning of a mammalian proton-coupled oligopeptide transporter.

Authors:  Y J Fei; Y Kanai; S Nussberger; V Ganapathy; F H Leibach; M F Romero; S K Singh; W F Boron; M A Hediger
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

Review 6.  Absorption of peptide and peptidomimetic drugs.

Authors:  G L Amidon; H J Lee
Journal:  Annu Rev Pharmacol Toxicol       Date:  1994       Impact factor: 13.820

7.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

Review 8.  Biology of membrane transport proteins.

Authors:  W Sadée; V Drübbisch; G L Amidon
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

9.  Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2.

Authors:  H Saito; K Inui
Journal:  Am J Physiol       Date:  1993-08

10.  Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization.

Authors:  R Liang; Y J Fei; P D Prasad; S Ramamoorthy; H Han; T L Yang-Feng; M A Hediger; V Ganapathy; F H Leibach
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

View more
  9 in total

Review 1.  Intestinal peptide transport systems and oral drug availability.

Authors:  C Y Yang; A H Dantzig; C Pidgeon
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

Review 2.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

3.  Sequence alignments of the H(+)-dependent oligopeptide transporter family PTR: inferences on structure and function of the intestinal PET1 transporter.

Authors:  R C Graul; W Sadée
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

4.  Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist.

Authors:  N Surendran; K M Covitz; H Han; W Sadee; D M Oh; G L Amidon; R M Williamson; C F Bigge; B H Stewart
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

5.  In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.

Authors:  Sean Ekins; Jeffrey S Johnston; Praveen Bahadduri; Vanessa M D'Souza; Abhijit Ray; Cheng Chang; Peter W Swaan
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

6.  Stable transfection of MDCK cells with epitope-tagged human PepT1.

Authors:  Chun Chu; Curtis T Okamoto; Sarah F Hamm-Alvarez; Vincent H L Lee
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

7.  Monitoring intracellular pH changes in response to osmotic stress and membrane transport activity using 5-chloromethylfluorescein.

Authors:  Aline Salvi; J Mark Quillan; Wolfgang Sadée
Journal:  AAPS PharmSci       Date:  2002

8.  Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.

Authors:  H K Han; D M Oh; G L Amidon
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

9.  Tracking dipeptides at work-uptake and intracellular fate in CHO culture.

Authors:  Andres Sánchez-Kopper; Max Becker; Jennifer Pfizenmaier; Christian Kessler; Andreas Karau; Ralf Takors
Journal:  AMB Express       Date:  2016-07-22       Impact factor: 3.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.